Cargando…
Dendritic-Tumor Fusion Cells Derived Heat Shock Protein70-Peptide Complex Has Enhanced Immunogenicity
Tumor-derived heat shock protein70-peptide complexes (HSP70.PC-Tu) have shown great promise in tumor immunotherapy due to numerous advantages. However, large-scale phase III clinical trials showed that the limited immunogenicity remained to be enhanced. In previous research, we demonstrated that hea...
Autores principales: | Zhang, Yunfei, Zhang, Yong, Chen, Jun, Liu, Yunyan, Luo, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427282/ https://www.ncbi.nlm.nih.gov/pubmed/25961716 http://dx.doi.org/10.1371/journal.pone.0126075 |
Ejemplares similares
-
Enhanced antitumor immunity of nanoliposome-encapsulated heat shock protein 70 peptide complex derived from dendritic tumor fusion cells
por: ZHANG, YUNFEI, et al.
Publicado: (2015) -
A new purification method for enhancing the immunogenicity of heat shock protein 70-peptide complexes
por: GAO, YANWEI, et al.
Publicado: (2012) -
Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation
por: Lu, Wen-Wen, et al.
Publicado: (2017) -
Purified Dendritic Cell-Tumor Fusion Hybrids Supplemented with Non-Adherent Dendritic Cells Fraction Are Superior Activators of Antitumor Immunity
por: Zhang, Yunfei, et al.
Publicado: (2014) -
A major immunogen in Schistosoma mansoni infections is homologous to the heat-shock protein Hsp70
Publicado: (1987)